Single-Use Bioprocessing Market Size is Forecasted to Reach USD 52.5 Billion by 2030 Says Precedence Research
The single-use bioprocessing market demand stood at 19 billion in 2020 and is forecast to reach 52.5 billion by 2030, growing at a healthy CAGR of 16.1% until FY2030, according to a 2021 study by Precedence Research, the Canada-based market Insight Company.
The report contains 150+ pages with detailed analysis and it is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1308
Single-use bioprocessing systems are known for developing pharmaceuticals such as medicines, vaccines, and monoclonal antibodies by using disposable or single-use technologies. The use of single-use bioprocessing technologies during the development phase of drugs has witnessed exponential growth in the past few years. The single-use bioprocessing technologies are being used increasingly by the contract manufacturers in biopharmaceutical industry for acquiring the benefits such as low investment, low environmental footprint, and reliability. This is one of the primary factors propelling the growth of the global single-use bioprocessing market.
The growing geriatric population is boosting the market growth significantly. The growing prevalence of chronic conditions and diseases amongst the old age population is boosting the demand for the biopharmaceutical medicines. According to the United Nations, the old age population of 65 years or above will reach up to 1.5 billion by 2050. This is estimated to foster the single-use bioprocessing market in the future. Moreover, increasing investments in the development of numerous vaccines, drugs, and diagnostic tests is positively impacting the market growth.
Market Report Scope
Report Highlights | Details |
Market Size | USD 52.5 Billion by 2030 |
Growth Rate | CAGR of 16.1% From 2021 to 2030 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Product, End User, Application, Workflow, Region |
Competition Landscape
In the final section of the research report, Precedence Research provided the global single-use bioprocessing market structure and a detailed competition landscape to provide a dashboard view of key players operating in the single-use bioprocessing market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.
Some of the major players in the single-use bioprocessing market include:
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corporation
- Corning Incorporated
- Eppendorf AG
- General Electric Company (GE Healthcare)
- Lonza
- Rentschler Biopharma SE
- JM BioConnect
- Meissner Filtration Products, Inc.
- Infors AG
- BoehringerIngelheim GmbH
- Entegris, Inc.
- PBS Biotech, Inc.
Crucial factors accountable for market growth are:
- Rapid growth of the biopharmaceutical industry
- Growing government investments in the development of vaccines and drugs
- Rapid technological developments by the key players
- Rising government expenditure on developing healthcare infrastructure
- Increasing activities of the contract development manufacturing organizations
- Growing popularity of disposables in the biopharmaceuticals
Report Highlights
- By product, the media bags and containers segment led the global single-use bioprocessing market with remarkable revenue share in 2020. This is due to the benefits associated with the media bags and containers such as low capital requirement, saving of cost in sterilization and cleaning, operating scale flexibility, quick batch changeover and quick deployment, and cleaning validation elimination.
- By application, the filtration segment led the global single-use bioprocessing market with remarkable revenue share in 2020. This is attributed to the increasing adoption of single-use bioprocessing system in filtration owing to its flexibility. It is applicable in a wide variety of biopharmaceutical applications depending on the type of solutions used and is very much effective in eliminating viruses and other such cultures.
- By End User, the biopharmaceutical manufacturer segment led the market in 2020 as rapid growth of biopharmaceuticals industry. Biopharmaceutical industry alone represents over 20% of the total pharmaceutical industry and is rapidly growing across the markets like North America and Europe.
Market Dynamics
Drivers – The single-use bioprocessing market is significantly driven by the growing demand from the biopharmaceutical industry. Majority of the biopharmaceutical companies are increasingly adopting the single-use bioprocessing technology because the single-use bioprocessing systems increases the efficiency in the process and reduces the costs associated with sterilization, cleaning, and maintenance of steel bioreactors. This drives the higher adoption of disposable bioprocessing systems in the biopharmaceutical industry.
Restraints – The Bio-Process System Alliance has published a set of tests to be performed regarding the extractable and leachable contamination. The leachable and extractable are the unwanted products produced by the single-use bioprocessing system. The disposable bioprocessing system are made of plastic and often faces contamination issues. This may hamper the single-use bioprocessing market growth.
Opportunities – The emerging markets such as China and India have a high growth potential. The growing investments by the major players, growing geriatric population, and rapidly growing biotechnology in the industry is providing lucrative growth opportunities to the single-use bioprocessing market players.
Challenges – The plastic wastes generated by the disposable bioprocessing system is a major challenge faced by the market players due to the growing environmental concerns and government regulation regarding plastic wastes.
Recent Developments
- In December 2020, Thermo Fisher Scientific launched a single-use bioreactor for manufacturing cell culture.
- In March 2020, GE Healthcare’s Biopharma business was acquired by Danaher Corporation and now Biopharma is renamed as Cytiva.
Market Segmentation
By Product
- Filtration Assemblies
- Disposable Bioreactors
- Disposable Mixers
- Media Bags & Containers
- Others
By Application
- Filtration
- Purification
- Cell Culture
- Others
By End User
- Biopharmaceutical Manufacturers
- Clinical & Academic Research Institutes
- Others
By Workflow
- Upstream
- Fermentation
- Downstream
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Why should you invest in this report?
If you are aiming to enter the global single-use bioprocessing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for single-use bioprocessing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1308
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Single-Use Bioprocessing Market, By Product
7.1. Single-Use Bioprocessing Market, by Product Type, 2021-2030
7.1.1. Filtration Assemblies
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Disposable Bioreactors
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Disposable Mixers
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Media Bags & Containers
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Single-Use Bioprocessing Market, By Application
8.1. Single-Use Bioprocessing Market, by Application, 2021-2030
8.1.1. Filtration
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Purification
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Cell Culture
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Single-Use Bioprocessing Market, By End User Type
9.1. Single-Use Bioprocessing Market, by End User Type, 2021-2030
9.1.1. Biopharmaceutical Manufacturers
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Clinical & Academic Research Institutes
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Single-Use Bioprocessing Market, By Workflow Type
10.1. Single-Use Bioprocessing Market, by Workflow Type, 2021-2030
10.1.1. Upstream
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Fermentation
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Downstream
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Single-Use Bioprocessing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.1.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.1.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.1.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.8.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.8.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.8.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.5.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.5.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Sartorius AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck KGaA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Pall Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Corning Incorporated
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Eppendorf AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. General Electric Company (GE Healthcare)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Lonza
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Rentschler Biopharma SE
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. JM BioConnect
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Meissner Filtration Products, Inc.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1308
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com